Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Vistagen Therapeutics Inc (NASDAQ: VTGN) was $2.98 for the day, down -1.97% from the previous closing price of $3.04. In other words, the price has decreased by -$1.97 from its previous closing price. On the day, 0.53 million shares were traded. VTGN stock price reached its highest trading level at $3.03 during the session, while it also had its lowest trading level at $2.91.
Ratios:
Our analysis of VTGN’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.98 and its Current Ratio is at 5.98. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.01.
On August 07, 2023, Maxim Group Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $30.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VTGN now has a Market Capitalization of 91427808 and an Enterprise Value of 30603804. For the stock, the TTM Price-to-Sale (P/S) ratio is 130.61 while its Price-to-Book (P/B) ratio in mrq is 1.54. Its current Enterprise Value per Revenue stands at 47.374 whereas that against EBITDA is -0.514.
Stock Price History:
The Beta on a monthly basis for VTGN is 0.53, which has changed by -0.016501665 over the last 52 weeks, in comparison to a change of 0.1653893 over the same period for the S&P500. Over the past 52 weeks, VTGN has reached a high of $3.88, while it has fallen to a 52-week low of $1.90. The 50-Day Moving Average of the stock is -1.56%, while the 200-Day Moving Average is calculated to be 12.13%.
Shares Statistics:
VTGN traded an average of 460.53K shares per day over the past three months and 368810 shares per day over the past ten days. A total of 29.28M shares are outstanding, with a floating share count of 27.73M. Insiders hold about 9.63% of the company’s shares, while institutions hold 55.81% stake in the company. Shares short for VTGN as of 1756425600 were 946396 with a Short Ratio of 2.06, compared to 1753920000 on 477221. Therefore, it implies a Short% of Shares Outstanding of 946396 and a Short% of Float of 5.0200000000000005.
Earnings Estimates
The company has 3.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.32, with high estimates of -$0.25 and low estimates of -$0.35.
Analysts are recommending an EPS of between -$1.33 and -$1.62 for the fiscal current year, implying an average EPS of -$1.48. EPS for the following year is -$1.5, with 3.0 analysts recommending between -$1.39 and -$1.71.
Revenue Estimates
A total of 5 analysts have provided revenue estimates for VTGN’s current fiscal year. The highest revenue estimate was $1.7M, while the lowest revenue estimate was $200k, resulting in an average revenue estimate of $577k. In the same quarter a year ago, actual revenue was $486k
